Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06883812 · ClinicalTrials.gov registry record · NA

Continuous Glucose Monitoring in Prediabetes With Health Education Videos Among Community Health Workers

A NA study, sponsored by David S Black, PhD.

Completed
Registry status
NA
Development phase
30
Enrollment target

NCT06883812: Completed NA study, sponsored by David S Black, PhD.

NCT06883812 is a NA study that has completed, run by David S Black, PhD. The registered enrollment target is 30 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06883812, a NA study, has completed, sponsored by David S Black, PhD.

COMPLETED
Registry status
NA
Development phase
30 participants
Enrollment target

Study Summary

The objective of this project is to deliver a behavior health education video series that combines wearable continuous glucose monitoring (CGM) with smartphone feedback and video clips generated by artificial intelligence (AI) software to improve glycemic control among individuals with prediabetes. The goal is to prevent transition to type 2 diabetes and advanced metabolic complications.

Primary Outcome

Mean glucose in mg/dL

Interventions

  • DEVICE CGM

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2025-03-05
Est. Completion 2025-11-03
Phase NA
David S Black, PhD

2 total trials

What the finished NCT06883812 record still lists

NCT06883812 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).

The record links to 0 conditions, and to 1 intervention - of which CGM is the first listed.

NCT06883812 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT06883812 about?

NCT06883812 is a clinical study titled "Continuous Glucose Monitoring in Prediabetes With Health Education Videos Among Community Health Workers". The objective of this project is to deliver a behavior health education video series that combines wearable continuous glucose monitoring (CGM) with smartphone feedback and video clips generated by artificial intelligence (AI) software to improve glycemic control among individuals with prediabetes. ...

What is the current status of trial NCT06883812?

This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2025-03-05. Estimated completion is 2025-11-03.

What interventions are being tested in trial NCT06883812?

The interventions under investigation include: CGM (DEVICE).

Who is sponsoring clinical trial NCT06883812?

This trial is sponsored by David S Black, PhD, which has 2 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT06883812's enrollment target sits among peer trials

30 1593rd of 2000 higher than 299 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00977977 · 30 participants · Phase 2

    Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy

  • NCT01459107 · 30 participants · Phase 2

    Human Upper Extremity Allotransplantation

  • NCT01666080 · 30 participants · NA

    Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)

  • NCT01720836 · 30 participants · Phase 1

    Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06883812, the US trial registry maintained by the National Library of Medicine. NCT06883812 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.